10-Q quarterly report · filed Nov 10, 2026

Paysign, Inc. (PAYS) Q3 2026 10-Q Quarterly Report

Short answer

Paysign, Inc. (PAYS) filed its Q3 2026 10-Q quarterly report on Nov 10, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $31M (up 42.6% year over year) with net income of $7M.

Q3 2026 key financials · XBRL

Revenue
$31M
+42.6% YoY · +9.0% QoQ
Net income
$7M
+204.1% YoY · −0.3% QoQ
Operating margin
23.8%
Gross margin
64.7%
EPS (diluted)
$0.10
+233.3% YoY · −9.1% QoQ

Source: XBRL data from the Paysign, Inc. (PAYS) Q3 2026 10-Q on SEC EDGAR. USD.

Paysign, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $30.8M, up 42.6% YoY from $21.6M
  • Pharma revenue $16.6M, up 109.8% YoY, strongest segment
  • Other revenue $353K, down 56.7% YoY, weakest line
  • Gross margin 64.7% vs 56.3%; net margin 21.9% vs 10.3% YoY
  • Operating cash flow $82.8M; cash $34.5M, up $13.5M from December 31, 2025
  • Headwind: plasma payment transition for 113 centers expected to reduce revenue and gross profit beginning Q4 2026 through 2027

Risk Factors

  • Smaller reporting company exemption: no Item 1A risk-factor disclosure required in this 10-Q

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Paysign, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.